ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

161–180 of 280 studies

E2 ModerateCohortPEM not requiredCross-Sectional

Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin.

Seshadri, N, Sonoda, L I, Lever, A M et al.·The Journal of infection·2012

This study compared two imaging tests for finding the cause of fever that doctors can't explain. One test (PET) was much better at detecting problems—finding a cause in 86% of patients—compared to the other test (leucocyte scintigraphy), which only found a cause in 20% of patients. PET scans successfully identified infections, inflammation, and other conditions causing unexplained fevers.

Evidence Atlas

Evidence browser

Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin.

Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.

NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome.

Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression.

Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.

Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays.

Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

Nitric oxide concentrations are normal and unrelated to activity level in chronic fatigue syndrome: a case-control study.

The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patients.

Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.

Longitudinal MRI shows no cerebral abnormality in chronic fatigue syndrome.

Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study.

Vitamin D metabolites as clinical markers in autoimmune and chronic disease.

Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker.

Hypocapnia is a biological marker for orthostatic intolerance in some patients with chronic fatigue syndrome.

Spectroscopic diagnosis of chronic fatigue syndrome by visible and near-infrared spectroscopy in serum samples.

Salivary cortisol as a predictor of postoperative fatigue.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research